Clinical Studies & Resources

Salonpas® allocates significant resources to clinical study and product innovation that keeps us aligned to the needs of pain sufferers and the professional guidance that recommends a “topicals first” approach to pain management.

Higashi Study

From a randomized, double-blind, parallel-group, placebo-controlled, multicenter study forming the basis of our New Drug Application approval.

Learn more

RELIEF Study

Observational study of benefits of Salonpas® Pain Relieving Patch on pain intensity, use of concurrent oral medications and BPI scores.

Learn more
Box of Salonpas Pain Relieving Patches with Maxtrix-like backdrop

AI Study

Applying artificial intelligence (AI) to patient profile reveals which ones could benefit most from Salonpas®.

Learn more

missing image

CDC

In response to the opioid crisis, the CDC released importance guidance for the use of topical analgesics as first line medicine.

Learn more

ACP & AAFP

These two academies released guidance that recommends a “topical NSAIDs first approach” for acute non-low back musculoskeletal pain.

Learn more

Dr. Gudin

Dr. Gudin Q&A

Esteemed doctor and Salonpas® Advisor shares his insights.

Learn more
Salonpas Pain Relief Patch products

#1 Doctor Recommended

If you’re recommending Salonpas® to your patients, you’re in good company.

Learn more